Research suggests that the two studies provided do not actually investigate colloidal gold or its effects on cognitive function. The available evidence consists of a 2009 animal study examining how the ApoE4 gene affects cerebral blood flow and mitochondrial function in mice, and a 2025 cellular biology study exploring how disruptions in the HOPS cellular machinery complex may contribute to the accumulation of toxic protein fragments associated with Alzheimer's disease — both of which are directionally neutral and focused on disease mechanisms rather than any gold-based intervention. Studies indicate that while these findings contribute to understanding potential pathways in cognitive decline and Alzheimer's disease, neither study examined colloidal gold as a treatment or supplement in any capacity. As such, no conclusions about colloidal gold and cognitive function can be drawn from this body of evidence, and readers seeking research on that specific topic should consult literature directly examining gold nanoparticle or colloidal gold interventions in neurological or cognitive contexts.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 m... | Other | 2009 | Neutral | 100 |
| HOPS disruption impairs APP trafficking and processing, promoting exosomal se... | Other | 2025 | Neutral | 85 |